📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses. (2018)

First Author: Halpin DMG

Attributed to: Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00119-2017

PubMed Identifier: 29750142

Publication URI: http://europepmc.org/abstract/MED/29750142

Type: Journal Article/Review

Volume: 4

Parent Publication: ERJ open research

Issue: 2

ISSN: 2312-0541